Item 1.01 | Entry into a Material Definitive Agreement |
On November 13, 2023, Carlyle Secured Lending, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and among the Company, Carlyle Global Credit Investment Management L.L.C. (the “Adviser”), and Carlyle Global Credit Administration L.L.C. (the “Administrator”), on the one hand, and Morgan Stanley & Co. LLC and UBS Securities LLC, as representatives of the several underwriters named in Schedule I thereto, on the other hand, in connection with the issuance and sale of $75,000,000 aggregate principal amount of the Company’s 8.20% Notes due 2028 (the “Notes” and the issuance and sale of the Notes, the “Offering”). The closing of the Offering is expected to occur on November 20, 2023, subject to customary closing conditions. The Company intends to list the Notes on the Nasdaq Global Select Market (“Nasdaq”), within 30 days of the original issue date under the trading symbol “CGBDL.” The Company also granted the underwriters a 30-day option to purchase up to an additional $10,000,000 aggregate principal amount of the Notes to cover over-allotments, if any. On November 14, 2023, the underwriters exercised their option to purchase an additional $10,000,000 aggregate principal amount of Notes.
The Underwriting Agreement includes customary representations, warranties, and covenants by the Company, the Adviser, and the Administrator. It also provides for customary indemnification by each of the Company, the Adviser, the Administrator, and the underwriters against certain liabilities and customary contribution provisions in respect of those liabilities.
The Offering was made pursuant to the Company’s effective shelf registration statement on Form N-2 (Registration No. 333-255589) previously filed with the Securities and Exchange Commission (the “SEC”), as supplemented by a preliminary prospectus supplement dated November 13, 2023, a final prospectus supplement dated November 13, 2023, and the pricing term sheet filed with the SEC on November 13, 2023. This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in their entirety by reference to the full text of the Underwriting Agreement filed as an exhibit hereto and incorporated by reference herein.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits:
* | Schedules and exhibits to this Exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company undertakes to furnish supplemental copies of any of the omitted schedules and exhibits to the Securities and Exchange Commission upon request. |